Medications

Research helps pave way for newly approved use of drug

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) ...

Medications

Breast cancer medication risk

New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.